{"name":"Medical Practice Prof D. Ivanov","slug":"medical-practice-prof-d-ivanov","ticker":"","exchange":"","domain":"","description":"Medical Practice Prof D. Ivanov is a specialized medical practice focused on the research and treatment of specific diseases, with a particular emphasis on developing innovative therapies. The practice has two drugs in its portfolio, one of which is already marketed, while the other is in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Direct renin inhibitor","genericName":"Direct renin inhibitor","slug":"direct-renin-inhibitor","indication":"Hypertension","status":"phase_2"}]}],"pipeline":[{"name":"Direct renin inhibitor","genericName":"Direct renin inhibitor","slug":"direct-renin-inhibitor","phase":"phase_2","mechanism":"A direct renin inhibitor blocks the enzyme renin, preventing the initial step of the renin-angiotensin-aldosterone system (RAAS) and reducing blood pressure.","indications":["Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOclhDLUNuVWJUMlpfdnhTVTBGLXlVS2hLVGhaZlNJWGxrUVU4dUYydkpQY0tndFhSWWtTdUttYkUyOXJiLU1tSnd3a0VYT1JMdmJaaDRsN0ZTbTZjUy1GelhtUHIwbnl5NGJLampLUTEyN2ltMEhwVGdnSHUtN0xOR1d1RkRndWl4Y0lNSG85dGV4ckJzbUlrb0diejE0ZHRBbU8xQ255UGJPNG9N?oc=5","date":"2024-03-27","type":"pipeline","source":"t-invariant.org","summary":"No more tolerance to Putin’s regime! An appeal from scholars of the world - t-invariant.org","headline":"No more tolerance to Putin’s regime! An appeal from scholars of the world - t","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}